Comparing Acura Pharmaceuticals

Comparing Acura Pharmaceuticals


Acura Pharmaceuticals and Flamel Technologies are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitabiliy and earnings. Acura Pharmaceuticals has a beta of 2.12, indicating that its share price is 112% more volatile than the S&P 500.



from Biotech News